The Medical Briefing  Nephrology

Lipoic acid, mercury and NELL1 membranous nephropathy, glyoxylic acid hair straightening, tolvaptan and dapagliflozin in polycystic kidney disease

Retrospective no. 10/12

The essentials in four articles

■ Glomerular disease
NELL1 and "non-classical" causes: after α-lipoic acid supplementation (4 cases) and use of mercury-containing traditional medicines (186 biopsies: 87.9% NELL1-positive in the exposed vs 5%), stopping the exposure led to remission, often without immunosuppression.

■ AKI and critical care
NEJM letter: recurrent acute kidney injury after hair straightening with glyoxylic acid, metabolized to oxalate; calcium oxalate crystals appear in mice after skin application. "Formaldehyde-free" products are not risk-free.

■ CKD and dialysis
340 ADPKD patients (median follow-up 5 years, 92 per group after matching): tolvaptan slows GFR decline by 14% (−3.75 vs −4.36 mL/min/1.73 m²/year), with no significant effect on total kidney volume growth.

■ CKD and dialysis
In ADPKD patients on tolvaptan, dapagliflozin attenuates GFR decline (+2.57 vs −5.65 mL/min/1.73 m²/year without dapagliflozin) and reduces total kidney volume growth (−0.44% vs +5.04%).